Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

If you will be receiving chemotherapy over a long period of time, or if you are a candidate for a blood or marrow transplantation, your healthcare provider may recommend a central line, or central ...

Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...

New catheter materials for peripherally inserted central catheters (PICCs) may reduce the risk of device failure due to infectious, thrombotic, and catheter occlusion events. However, data from ...

Patients already treated don’t need to do anything. Boston Scientific has updated its instructions for doctors using catheter technology to treat atrial fibrillation with extreme cooling ...

If you were injured by a dangerous or defective product, you may be eligible to file a lawsuit to pursue compensation for any ...

Q2 2025 Earnings Call Transcript January 8, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.04, ...

Xeltis announced today that it completed enrollment in an EU pivotal trial for aXess, its restorative vascular access conduit ...

Bloodstream infections (BSI) have a substantial impact on morbidity and mortality worldwide. Despite scarcity of data from many low- and middle-income countries (LMICs), there is increasing awareness ...

"Buckle your seatbelt, Dorothy, 'cause Kansas is going bye-bye," Cypher says this in The Matrix to prepare Neo for a mind-bending reality. After 2024's AI break ...

Q2 2025 Earnings Conference Call January 8, 2025 8:00 AM ETCompany ParticipantsJim Clemmer - President and Chief ...